Cardiovascular Systems Inc
F:R7Y1
Operating Margin
Cardiovascular Systems Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
C
|
Cardiovascular Systems Inc
F:R7Y1
|
755.4m EUR |
-16%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.5B USD |
18%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
185B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
153.5B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
148B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
115B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
51.2B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.3B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.1B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.1B USD |
29%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
38.3B USD |
32%
|
Cardiovascular Systems Inc
Glance View
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. The company is headquartered in St. Paul, Minnesota and currently employs 780 full-time employees. The company went IPO on 2006-06-28. The firm has developed patented orbital atherectomy systems (OAS) for both peripheral and coronary clinical applications. The primary base of its business is catheter-based platforms capable of treating a range of vessel sizes and plaque types, including calcified plaque. Its coronary artery disease (CAD) product, the Diamondback 360 Coronary OAS (Coronary OAS), which is a catheter-based platform designed to facilitate stent delivery in patients with CAD who are acceptable candidates for percutaneous transluminal coronary angioplasty or stenting due to de novo, severely calcified coronary artery lesions.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Cardiovascular Systems Inc's most recent financial statements, the company has Operating Margin of -16.1%.
You don't have any saved screeners yet